Literature DB >> 20130500

Stromal compartment as a survival prognostic factor in advanced ovarian carcinoma.

Alexandre Labiche1, Natacha Heutte, Paulette Herlin, Jacques Chasle, Pascal Gauduchon, Nicolas Elie.   

Abstract

OBJECTIVE: We investigated the prognostic significance of stromal compartment on the overall survival of patients with advanced epithelial ovarian cancer.
METHODS: We evaluated retrospectively the stroma proportion of the tumor surgical specimens of 194 patients with stages III and IV disease, using histochemical staining and fully automatic virtual slide processing. The prognostic significance of stroma proportion and clinical parameters were evaluated using log-rank test and Cox regression.
RESULTS: Stroma proportion was found to be an independent prognostic factor by both univariate (P = 0.016) and multivariate analyses (hazards ratio = 1.45, P = 0.011).
CONCLUSION: The present data indicate that a high stroma proportion is related to a poor prognosis of stage III and IV ovarian carcinomas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130500     DOI: 10.1111/IGC.0b013e3181bda1cb

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  31 in total

1.  Stromal responses among common carcinomas correlated with clinicopathologic features.

Authors:  Julia L-Y Chen; Iñigo Espinosa; Albert Y Lin; Olivia Y-W Liao; Matt van de Rijn; Robert B West
Journal:  Clin Cancer Res       Date:  2013-06-26       Impact factor: 12.531

2.  Cancer-associated stroma significantly contributes to the mesenchymal subtype signature of serous ovarian cancer.

Authors:  Qing Zhang; Chen Wang; William A Cliby
Journal:  Gynecol Oncol       Date:  2018-11-15       Impact factor: 5.482

3.  Granulosa Cell-Specific Brca1 Loss Alone or Combined with Trp53 Haploinsufficiency and Transgenic FSH Expression Fails to Induce Ovarian Tumors.

Authors:  Dannielle H Upton; Emily S Fuller; Emily K Colvin; Kirsty A Walters; Mark Jimenez; Reena Desai; David J Handelsman; Viive M Howell; Charles M Allan
Journal:  Horm Cancer       Date:  2015-05-06       Impact factor: 3.869

4.  NPPB is a novel candidate biomarker expressed by cancer-associated fibroblasts in epithelial ovarian cancer.

Authors:  Kate Lawrenson; Barbara Grun; Nathan Lee; Paulette Mhawech-Fauceglia; Jenny Kan; Steve Swenson; Yvonne G Lin; Tanja Pejovic; Joshua Millstein; Simon A Gayther
Journal:  Int J Cancer       Date:  2014-08-14       Impact factor: 7.396

Review 5.  Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer.

Authors:  Isaiah G Schauer; Anil K Sood; Samuel Mok; Jinsong Liu
Journal:  Neoplasia       Date:  2011-05       Impact factor: 5.715

6.  Regulation of chemo-sensitivity in ovarian cancer via a stroma dependent glutathione pathway.

Authors:  Derek B Oien; Jeremy Chien; Nikki Cheng
Journal:  Transl Cancer Res       Date:  2016-09       Impact factor: 1.241

Review 7.  Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response.

Authors:  Matthew David Hale; Jeremy David Hayden; Heike Irmgard Grabsch
Journal:  Cell Oncol (Dordr)       Date:  2013-03-14       Impact factor: 6.730

8.  Microenvironmental InterFereNce of metabolism regulates chemosensitivity.

Authors:  Leila Akkari; Johanna A Joyce
Journal:  Cell Res       Date:  2016-06-28       Impact factor: 25.617

Review 9.  Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.

Authors:  Tsz-Lun Yeung; Cecilia S Leung; Kay-Pong Yip; Chi Lam Au Yeung; Stephen T C Wong; Samuel C Mok
Journal:  Am J Physiol Cell Physiol       Date:  2015-07-29       Impact factor: 4.249

10.  Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens.

Authors:  Allison L Hunt; Nicholas W Bateman; Waleed Barakat; Sasha Makohon-Moore; Brian L Hood; Kelly A Conrads; Ming Zhou; Valerie Calvert; Mariaelena Pierobon; Jeremy Loffredo; Tracy J Litzi; Julie Oliver; Dave Mitchell; Glenn Gist; Christine Rojas; Brian Blanton; Emma L Robinson; Kunle Odunsi; Anil K Sood; Yovanni Casablanca; Kathleen M Darcy; Craig D Shriver; Emanuel F Petricoin; Uma N M Rao; G Larry Maxwell; Thomas P Conrads
Journal:  iScience       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.